|
V.A. Sharbabchiev, Kh.S. Ibishev, N.I. Volkova, Z.R. Gusova, M.I. Kogan
Adverse events after discontinuation of testosterone preparationsя, used for non-medical purposes
|
№5 / 2023
|
|
V.V. Sergeev, V.N. Pavlov, V.L. Medvedev, V.V. Churbakov
The role of the androgen receptor, testosterone and related factors in the development of urolithiasis
|
№5 / 2023
|
|
А.А. Kamalov, O.Yu. Nesterova, V.Yu. Mareev, Ia.A. Orlova, Yu.V. Mareev, Yu L. Begrambekova, Z.Sh. Pavlova, A.G. Plisyk, L.M. Samokhodskaya, E.A. Mershina, D.A. Ohobotov, A.A. Strigunov, D.D. Tsurskaya
Androgenic status of men with severe COVID-19: the role of testosterone and dihydrotestosterone [within the program FOUNDER (features of a new coronavirus infection course and options therapy depending on the androgenic status)]
|
№3 / 2023
|
|
I.A. Tyuzikov, Yu.A. Tishova
Evolution of views on the etiology and pathogenesis of lower urinary tract symptoms for men
|
№5 / 2022
|
|
A.A. Kamalov, O.Yu. Nesterova, Ya.A. Orlova, V.Yu. Mareev, Yu.V. Mareev, Z.Sh. Pavlova, D.A. Okhobotov, A.A. Strigunov, R.P. Vasilevsky, O.M. Nesuk, V.V. Demkin
Protective potential of 5-alpha-reductase inhibitors on Covid19 incidence and severity: results from retrospective cohort study FOUNDER (features of a new coronavirus infection course and options therapy depending on the androgenic status)
|
№5 / 2022
|
|
Kh.S. Ibishev, N.I. Volkova, Z.R. Gusova, P.A. Evseev, M.I. Kogan
Genitourinary adverse events in men using nonmedical testosterone preparations
|
№3 / 2022
|
|
N.D. Akhvlediani, I.A. Reva, A.S. Chernushenko, D.Yu. Pushkar
Andrological aspects of new coronavirus infection Covid-19
|
№6 / 2021
|
|
А.А. Kamalov, V.Yu. Mareev, Ia.A. Orlova, D.A. Ohobotov, Yu.V. Mareev, Yu L. Begrambekova, Z.Sh. Pavlova,
A.G. Plisyk, L.M. Samokhodskaya, E.A. Mershina,
A.A. Tretyakov, O.Yu. Nesterova, A.S. Shurygina
Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity
|
№6 / 2021
|
|
A.V. Kuz’menko, V.V. Kuz’menko, T.A. Gyaurgiev
Chronobiological features of different regimens of testosterone gel therapy in men with androgen deficiency
|
№4 / 2018
|
|
A.G. Martov, D.V. Ergakov
Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?
|
№6 / 2016
|
|
I.I. Belousov, M.I. Kogan, H.S. Ibishev, S.V. Vorobyev, I.A. Khripun, Z.R. Gusova
Penile dimensions in type 2 diabetes
|
№6 / 2015
|
|
A.L. Vertkin, L.Yu. Morgunov, Kh. A. Shakhmanaev
Hypogonadism and chronic obstructive pulmonary disease
|
№5 / 2013
|
Русский
